{"transactions":[{"id":1353792,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":85723,"kind":"person","name":"Fischesser Ryan","position":1,"cik":"0001871155","reported_name":"Fischesser Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance and Controller"}}],"security":"Common Stock","published_at":"2024-11-22T21:01:32.000Z","date":"2024-11-20","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects restricted stock units (\"RSUs\") that will vest in full on November 20, 2025, subject to the reporting person's continued services to the Issuer through the vesting date. The RSUs will be settled in stock within 30 days after each vesting date."}],"balance_after":118854,"source":{"system":"sec-edgar","filing":"0001871155-24-000005","document":"wk-form4_1732309285.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000187115524000005/wk-form4_1732309285.xml","form_type":"4"}},{"id":2140064,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":85723,"kind":"person","name":"Fischesser Ryan","position":1,"cik":"0001871155","reported_name":"Fischesser Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance and Controller"}}],"security":"Option to purchase Common Stock","published_at":"2022-10-07T21:13:51.000Z","date":"2022-10-06","kind":"exercise","acquired":false,"shares":2839,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/4th of the shares subject to this option vested on January 1, 2022 and an additional 1/48th of the aggregate number of shares subject to the option have vested or will vest on the corresponding day of each month thereafter until the option is fully vested on January 1, 2025, subject to the reporting person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":15337,"derivative":{"exercise_price":4.11,"expiration_date":"2031-03-29","underlying":"Common Stock","underlying_shares":2839},"source":{"system":"sec-edgar","filing":"0001619856-22-000003","document":"wf-form4_166517721515147.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000161985622000003/wf-form4_166517721515147.xml","form_type":"4"}},{"id":2140063,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":85723,"kind":"person","name":"Fischesser Ryan","position":1,"cik":"0001871155","reported_name":"Fischesser Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance and Controller"}}],"security":"Option to purchase Common Stock","published_at":"2022-10-07T21:13:51.000Z","date":"2022-10-06","kind":"exercise","acquired":false,"shares":2839,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4th of the shares subject to this option vested on January 1, 2020 and an additional 1/48th of the aggregate number of shares subject to the option have vested or will vest on the corresponding day of each month thereafter until the option is fully vested on January 1, 2023, subject to the reporting person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":1704,"derivative":{"exercise_price":2.69,"expiration_date":"2029-03-18","underlying":"Common Stock","underlying_shares":2839},"source":{"system":"sec-edgar","filing":"0001619856-22-000003","document":"wf-form4_166517721515147.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000161985622000003/wf-form4_166517721515147.xml","form_type":"4"}},{"id":2140062,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":85723,"kind":"person","name":"Fischesser Ryan","position":1,"cik":"0001871155","reported_name":"Fischesser Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance and Controller"}}],"security":"Common Stock","published_at":"2022-10-07T21:13:51.000Z","date":"2022-10-06","kind":"exercise","acquired":true,"shares":2839,"price":4.11,"value":11668.29,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,848 shares represented by restricted stock units (\"RSUs\") that vest in two equal annual installments beginning on August 22, 2023, subject to the reporting person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":116044,"source":{"system":"sec-edgar","filing":"0001619856-22-000003","document":"wf-form4_166517721515147.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000161985622000003/wf-form4_166517721515147.xml","form_type":"4"}},{"id":2140061,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":85723,"kind":"person","name":"Fischesser Ryan","position":1,"cik":"0001871155","reported_name":"Fischesser Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance and Controller"}}],"security":"Common Stock","published_at":"2022-10-07T21:13:51.000Z","date":"2022-10-06","kind":"exercise","acquired":true,"shares":2839,"price":2.69,"value":7636.91,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,848 shares represented by restricted stock units (\"RSUs\") that vest in two equal annual installments beginning on August 22, 2023, subject to the reporting person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":113205,"source":{"system":"sec-edgar","filing":"0001619856-22-000003","document":"wf-form4_166517721515147.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000161985622000003/wf-form4_166517721515147.xml","form_type":"4"}},{"id":2140060,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":85723,"kind":"person","name":"Fischesser Ryan","position":1,"cik":"0001871155","reported_name":"Fischesser Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance and Controller"}}],"security":"Common Stock","published_at":"2022-10-07T21:13:51.000Z","date":"2022-10-06","kind":"sale","acquired":false,"shares":10000,"price":10.7958,"value":107958.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.67 to $10.94, inclusive. The reporting person undertakes to provide to Caribou Biosciences, Inc., any security holder of Caribou Biosciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,848 shares represented by restricted stock units (\"RSUs\") that vest in two equal annual installments beginning on August 22, 2023, subject to the reporting person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":110366,"source":{"system":"sec-edgar","filing":"0001619856-22-000003","document":"wf-form4_166517721515147.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000161985622000003/wf-form4_166517721515147.xml","form_type":"4"}},{"id":2174664,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":85723,"kind":"person","name":"Fischesser Ryan","position":1,"cik":"0001871155","reported_name":"Fischesser Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance and Controller"}}],"security":"Common Stock","published_at":"2022-08-24T21:25:18.000Z","date":"2022-08-22","kind":"grant","acquired":true,"shares":4848,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\") that vest in two equal annual installments beginning on August 22, 2023, subject to the reporting person's continued service to the Issuer through the applicable vesting dates. The RSUs will be settled in stock within 30 days after each vesting date."}],"balance_after":120366,"source":{"system":"sec-edgar","filing":"0001209191-22-047368","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000120919122047368/doc4.xml","form_type":"4"}},{"id":2278982,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":85723,"kind":"person","name":"Fischesser Ryan","position":1,"cik":"0001871155","reported_name":"Fischesser Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance and Controller"}}],"security":"Option to purchase Common Stock","published_at":"2022-05-06T23:28:44.000Z","date":"2022-05-05","kind":"exercise","acquired":false,"shares":1138,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4th of the shares subject to this option vested on January 1, 2022 and an additional 1/48th of the aggregate number of shares subject to the option have vested or will vest on the corresponding day of each month thereafter until the option is fully vested on January 1, 2025, subject to the reporting person's continued service to the Issuer through the applicable vesting dates. The vesting schedule for this option was inadvertently described incorrectly in the reporting person's Form 3 filed on July 23, 2021."}],"balance_after":18176,"derivative":{"exercise_price":4.11,"expiration_date":"2031-03-29","underlying":"Common Stock","underlying_shares":1138},"source":{"system":"sec-edgar","filing":"0001209191-22-027696","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000120919122027696/doc4.xml","form_type":"4"}},{"id":2278981,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":85723,"kind":"person","name":"Fischesser Ryan","position":1,"cik":"0001871155","reported_name":"Fischesser Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance and Controller"}}],"security":"Option to purchase Common Stock","published_at":"2022-05-06T23:28:44.000Z","date":"2022-05-05","kind":"exercise","acquired":false,"shares":1136,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Due to a rounding error, the exercise price for this stock option was inadvertently originally reported as $2.68 per share on the reporting person's Form 3 filed on July 23, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4th of the shares subject to this option vested on January 1, 2020 and an additional 1/48th of the aggregate number of shares subject to the option have vested or will vest on the corresponding day of each month thereafter so that the option is fully vested on January 1, 2023, subject to the reporting person's continues service to the Issuer through the applicable vesting dates."}],"balance_after":4543,"derivative":{"exercise_price":2.69,"expiration_date":"2029-03-18","underlying":"Common Stock","underlying_shares":1136},"source":{"system":"sec-edgar","filing":"0001209191-22-027696","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000120919122027696/doc4.xml","form_type":"4"}},{"id":2278980,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":85723,"kind":"person","name":"Fischesser Ryan","position":1,"cik":"0001871155","reported_name":"Fischesser Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance and Controller"}}],"security":"Common Stock","published_at":"2022-05-06T23:28:44.000Z","date":"2022-05-05","kind":"exercise","acquired":true,"shares":1138,"price":4.11,"value":4677.18,"ownership":{"direct":true},"balance_after":115518,"source":{"system":"sec-edgar","filing":"0001209191-22-027696","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000120919122027696/doc4.xml","form_type":"4"}},{"id":2278979,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":85723,"kind":"person","name":"Fischesser Ryan","position":1,"cik":"0001871155","reported_name":"Fischesser Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance and Controller"}}],"security":"Common Stock","published_at":"2022-05-06T23:28:44.000Z","date":"2022-05-05","kind":"exercise","acquired":true,"shares":1136,"price":2.69,"value":3055.84,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Due to a rounding error, the exercise price for this stock option was inadvertently originally reported as $2.68 per share on the reporting person's Form 3 filed on July 23, 2021."}],"balance_after":114380,"source":{"system":"sec-edgar","filing":"0001209191-22-027696","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000120919122027696/doc4.xml","form_type":"4"}},{"id":2326242,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":85723,"kind":"person","name":"Fischesser Ryan","position":1,"cik":"0001871155","reported_name":"Fischesser Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance and Controller"}}],"security":"Option to purchase Common Stock","published_at":"2022-03-17T23:14:43.000Z","date":"2022-03-15","kind":"exercise","acquired":false,"shares":1138,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/4th of the shares subject to this option vested on January 1, 2022 and an additional 1/48th of the aggregate number of shares subject to the option have vested or will vest on the corresponding day of each month thereafter until the option is fully vested on January 1, 2025, subject to the reporting person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":19314,"derivative":{"exercise_price":4.11,"expiration_date":"2031-03-29","underlying":"Common Stock","underlying_shares":1138},"source":{"system":"sec-edgar","filing":"0001209191-22-019808","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000120919122019808/doc4.xml","form_type":"4"}},{"id":2326241,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":85723,"kind":"person","name":"Fischesser Ryan","position":1,"cik":"0001871155","reported_name":"Fischesser Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance and Controller"}}],"security":"Option to purchase Common Stock","published_at":"2022-03-17T23:14:43.000Z","date":"2022-03-15","kind":"exercise","acquired":false,"shares":1136,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Due to a rounding error, the exercise price for this stock option was inadvertently originally reported as $2.68 per share on the reporting person's Form 3 filed on July 23, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4th of the shares subject to this option vested on January 1, 2020 and an additional 1/48th of the aggregate number of shares subject to the option have vested or will vest on the corresponding day of each month thereafter until the option is fully vested on January 1, 2023, subject to the reporting person's continued service to the Issuer through the applicable vesting dates. The vesting schedule for this option was inadvertently described incorrectly in the reporting person's Form 3 filed on July 23, 2021."}],"balance_after":5679,"derivative":{"exercise_price":2.69,"expiration_date":"2029-03-18","underlying":"Common Stock","underlying_shares":1136},"source":{"system":"sec-edgar","filing":"0001209191-22-019808","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000120919122019808/doc4.xml","form_type":"4"}},{"id":2326240,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":85723,"kind":"person","name":"Fischesser Ryan","position":1,"cik":"0001871155","reported_name":"Fischesser Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance and Controller"}}],"security":"Common Stock","published_at":"2022-03-17T23:14:43.000Z","date":"2022-03-15","kind":"exercise","acquired":true,"shares":1138,"price":4.11,"value":4677.18,"ownership":{"direct":true},"balance_after":113244,"source":{"system":"sec-edgar","filing":"0001209191-22-019808","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000120919122019808/doc4.xml","form_type":"4"}},{"id":2326239,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":85723,"kind":"person","name":"Fischesser Ryan","position":1,"cik":"0001871155","reported_name":"Fischesser Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance and Controller"}}],"security":"Common Stock","published_at":"2022-03-17T23:14:43.000Z","date":"2022-03-15","kind":"exercise","acquired":true,"shares":1136,"price":2.69,"value":3055.84,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Due to a rounding error, the exercise price for this stock option was inadvertently originally reported as $2.68 per share on the reporting person's Form 3 filed on July 23, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,888 shares purchased pursuant to the Issuer's 2021 Employee Stock Purchase Plan on February 15, 2022 for $9.85 per share."}],"balance_after":112106,"source":{"system":"sec-edgar","filing":"0001209191-22-019808","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000120919122019808/doc4.xml","form_type":"4"}},{"id":2436476,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":85723,"kind":"person","name":"Fischesser Ryan","position":1,"cik":"0001871155","reported_name":"Fischesser Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance and Controller"}}],"security":"Option to purchase Common Stock","published_at":"2022-01-12T21:35:21.000Z","date":"2022-01-11","kind":"other","acquired":false,"shares":6818,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/4th of the shares subject to this option vested on January 1, 2022 and an additional 1/48th of the aggregate number of shares subject to the option have vested or will vest on the corresponding day of each month thereafter, subject to the reporting person's continued services to the Issuer through the applicable vesting dates."}],"balance_after":20452,"derivative":{"exercise_price":4.11,"expiration_date":"2031-03-29","underlying":"Common Stock","underlying_shares":6818},"source":{"system":"sec-edgar","filing":"0001209191-22-003062","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000120919122003062/doc4.xml","form_type":"4"}},{"id":2436475,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":85723,"kind":"person","name":"Fischesser Ryan","position":1,"cik":"0001871155","reported_name":"Fischesser Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance and Controller"}}],"security":"Option to purchase Common Stock","published_at":"2022-01-12T21:35:21.000Z","date":"2022-01-11","kind":"other","acquired":false,"shares":569,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The exercise price for this stock option was incorrectly reported as $2.68 per share on the reporting person's Form 3 filed on July 23, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option have vested or will vest in equal monthly installments until the option is fully vested on January 1, 2023, subject to the reporting person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":6815,"derivative":{"exercise_price":2.69,"expiration_date":"2029-03-18","underlying":"Common Stock","underlying_shares":569},"source":{"system":"sec-edgar","filing":"0001209191-22-003062","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000120919122003062/doc4.xml","form_type":"4"}},{"id":2436474,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":85723,"kind":"person","name":"Fischesser Ryan","position":1,"cik":"0001871155","reported_name":"Fischesser Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance and Controller"}}],"security":"Common Stock","published_at":"2022-01-12T21:35:21.000Z","date":"2022-01-11","kind":"purchase","acquired":true,"shares":6818,"price":4.11,"value":28021.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired pursuant to the exercise of a stock option, as reported in Table II below."}],"balance_after":109082,"source":{"system":"sec-edgar","filing":"0001209191-22-003062","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000120919122003062/doc4.xml","form_type":"4"}},{"id":2436473,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":85723,"kind":"person","name":"Fischesser Ryan","position":1,"cik":"0001871155","reported_name":"Fischesser Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance and Controller"}}],"security":"Common Stock","published_at":"2022-01-12T21:35:21.000Z","date":"2022-01-11","kind":"purchase","acquired":true,"shares":569,"price":2.69,"value":1530.61,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired pursuant to the exercise of a stock option, as reported in Table II below."}],"balance_after":102264,"source":{"system":"sec-edgar","filing":"0001209191-22-003062","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000120919122003062/doc4.xml","form_type":"4"}},{"id":2462003,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":85723,"kind":"person","name":"Fischesser Ryan","position":1,"cik":"0001871155","reported_name":"Fischesser Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance and Controller"}}],"security":"Option to purchase Common Stock","published_at":"2021-12-21T22:23:26.000Z","date":"2021-12-20","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to this option will vest in equal monthly installments starting on the first monthly anniversary of the grant date until the option is fully vested on December 20, 2025, subject to the reporting person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":40000,"derivative":{"exercise_price":15.16,"expiration_date":"2031-12-19","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-21-070797","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000120919121070797/doc4.xml","form_type":"4"}},{"id":2462002,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":85723,"kind":"person","name":"Fischesser Ryan","position":1,"cik":"0001871155","reported_name":"Fischesser Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance and Controller"}}],"security":"Option to purchase Common Stock","published_at":"2021-12-21T22:23:26.000Z","date":"2021-12-20","kind":"other","acquired":false,"shares":1136,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The exercise price for this stock option was incorrectly reported as $2.68 per share on the reporting person's Form 3 filed on July 23, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option have vested or will vest in equal monthly installments until the option is fully vested on January 1, 2023, subject to the reporting person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":7384,"derivative":{"exercise_price":2.69,"expiration_date":"2029-03-18","underlying":"Common Stock","underlying_shares":1136},"source":{"system":"sec-edgar","filing":"0001209191-21-070797","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000120919121070797/doc4.xml","form_type":"4"}},{"id":2462001,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":85723,"kind":"person","name":"Fischesser Ryan","position":1,"cik":"0001871155","reported_name":"Fischesser Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance and Controller"}}],"security":"Common Stock","published_at":"2021-12-21T22:23:26.000Z","date":"2021-12-20","kind":"purchase","acquired":true,"shares":1136,"price":2.69,"value":3055.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired pursuant to the exercise of a stock option, as reported in Table II below."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The exercise price for this stock option was incorrectly reported as $2.68 per share on the reporting person's Form 3 filed on July 23, 2021."}],"balance_after":101695,"source":{"system":"sec-edgar","filing":"0001209191-21-070797","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000120919121070797/doc4.xml","form_type":"4"}},{"id":2544140,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":85723,"kind":"person","name":"Fischesser Ryan","position":1,"cik":"0001871155","reported_name":"Fischesser Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance and Controller"}}],"security":"Option to purchase Common Stock","published_at":"2021-10-12T23:33:00.000Z","date":"2021-10-11","kind":"other","acquired":false,"shares":1746,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The exercise price for this stock option was incorrectly reported as $2.68 per share on the reporting person's Form 3 filed on July 23, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option have vested or will vest in equal monthly installments until the option is fully vested on January 1, 2023, subject to the reporting person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":8520,"derivative":{"exercise_price":2.69,"expiration_date":"2029-03-18","underlying":"Common Stock","underlying_shares":1746},"source":{"system":"sec-edgar","filing":"0001209191-21-060289","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000120919121060289/doc4.xml","form_type":"4"}},{"id":2544139,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":85723,"kind":"person","name":"Fischesser Ryan","position":1,"cik":"0001871155","reported_name":"Fischesser Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance and Controller"}}],"security":"Common Stock","published_at":"2021-10-12T23:33:00.000Z","date":"2021-10-11","kind":"purchase","acquired":true,"shares":1746,"price":2.69,"value":4696.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired pursuant to the exercise of a stock option, as reported in Table II below."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The exercise price for this stock option was incorrectly reported as $2.68 per share on the reporting person's Form 3 filed on July 23, 2021."}],"balance_after":100559,"source":{"system":"sec-edgar","filing":"0001209191-21-060289","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000120919121060289/doc4.xml","form_type":"4"}}]}